首页 > 最新文献

Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive最新文献

英文 中文
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study. 在COVID-19中实际使用含瑞德西韦方案:一项回顾性病例对照研究
Francesco Cogliati Dezza, A. Oliva, V. Mauro, F. Romani, R. Aronica, G. Savelloni, E. Casali, S. Valeri, F. Cancelli, C. Mastroianni
BackgroundRemdesivir (REM) has shown potent antiviral activity in vitro and efficacy in animal models of COVID-19; nevertheless, clinical trials and real-life reports have shown conflicting data on its effectiveness. Aims of the study were to evaluate the impact of remdesivir on I) Intensive Care Unit (ICU) admission, II) need for orotracheal intubation (OTI) and III) in-hospital mortality. Furthermore, we estimated the kinetics of laboratory parameters and assessed the risk factors for in-hospital mortality in the remdesivir population.MethodsWe conducted a retrospective, single-center, case-control (1:1) study including hospitalized patients with confirmed SARS-CoV-2 infection. Cases were patients treated with remdesivir for 5 days, controls were patients not receiving remdesivir.ResultsA total of 192 patients (96 cases and 96 controls) were included in the study. Patients receiving remdesivir had a lower rate of ICU admission and need for OTI than controls, whereas no difference between cases and controls were observed as for mortality rate. However, at multivariable analysis remdesivir was not associated with ICU admission neither with OTI. Instead, presence of haematological malignancies, lower duration of symptoms, higher severity of infection and low lymphocytes count at admission were independently associated with in-hospital mortality. In patients treated with remdesivir a low albumin value and duration of lymphopenia were significantly associated with mortality.ConclusionsOur real-life study showed that therapy with remdesivir did not have impact on either ICU admission, need for OTI or in-hospital mortality.
瑞德西韦(remdesivir, REM)在体外和COVID-19动物模型中显示出强大的抗病毒活性;然而,临床试验和实际报告显示了其有效性的相互矛盾的数据。本研究的目的是评估瑞德西韦对以下因素的影响:1)重症监护病房(ICU)入院;2)口气管插管(OTI)需求;3)住院死亡率。此外,我们估计了实验室参数的动力学,并评估了瑞德西韦人群中住院死亡率的危险因素。方法采用回顾性、单中心、病例对照(1:1)研究,纳入住院确诊的SARS-CoV-2感染患者。病例为接受瑞德西韦治疗5天的患者,对照组为未接受瑞德西韦治疗的患者。结果共纳入192例患者,其中96例为病例,96例为对照组。接受瑞德西韦治疗的患者ICU入院率和OTI需求低于对照组,而死亡率在病例和对照组之间没有差异。然而,在多变量分析中,瑞德西韦与ICU入院和OTI均无相关性。相反,血液系统恶性肿瘤的存在、较短的症状持续时间、较高的感染严重程度和入院时淋巴细胞计数低与住院死亡率独立相关。在接受瑞德西韦治疗的患者中,低白蛋白值和淋巴细胞减少的持续时间与死亡率显著相关。结论一项现实研究表明,瑞德西韦治疗对ICU住院率、OTI需求和住院死亡率均无影响。
{"title":"Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study.","authors":"Francesco Cogliati Dezza, A. Oliva, V. Mauro, F. Romani, R. Aronica, G. Savelloni, E. Casali, S. Valeri, F. Cancelli, C. Mastroianni","doi":"10.53854/liim-3002-6","DOIUrl":"https://doi.org/10.53854/liim-3002-6","url":null,"abstract":"Background\u0000Remdesivir (REM) has shown potent antiviral activity in vitro and efficacy in animal models of COVID-19; nevertheless, clinical trials and real-life reports have shown conflicting data on its effectiveness. Aims of the study were to evaluate the impact of remdesivir on I) Intensive Care Unit (ICU) admission, II) need for orotracheal intubation (OTI) and III) in-hospital mortality. Furthermore, we estimated the kinetics of laboratory parameters and assessed the risk factors for in-hospital mortality in the remdesivir population.\u0000\u0000\u0000Methods\u0000We conducted a retrospective, single-center, case-control (1:1) study including hospitalized patients with confirmed SARS-CoV-2 infection. Cases were patients treated with remdesivir for 5 days, controls were patients not receiving remdesivir.\u0000\u0000\u0000Results\u0000A total of 192 patients (96 cases and 96 controls) were included in the study. Patients receiving remdesivir had a lower rate of ICU admission and need for OTI than controls, whereas no difference between cases and controls were observed as for mortality rate. However, at multivariable analysis remdesivir was not associated with ICU admission neither with OTI. Instead, presence of haematological malignancies, lower duration of symptoms, higher severity of infection and low lymphocytes count at admission were independently associated with in-hospital mortality. In patients treated with remdesivir a low albumin value and duration of lymphopenia were significantly associated with mortality.\u0000\u0000\u0000Conclusions\u0000Our real-life study showed that therapy with remdesivir did not have impact on either ICU admission, need for OTI or in-hospital mortality.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75187140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Screening of group B Streptococcus infection in pregnancy and neonatal outcomes in the province of Trento, Italy. 意大利特伦托省孕期 B 群链球菌感染筛查与新生儿预后。
Silvano Piffer, Roberto Rizzello, Mariangela Pedron, Laura Dellanna, Anna Lina Lauriola

The study analyzes the trend of group B streptococcal (GBS) infection in pregnancy in the province of Trento, Italy, where a universal screening of GBS infection in pregnancy has been active for some time. Data from pregnant women who gave birth at local maternity units between 2015-2019 were obtained from birth attendance certificates (BAC), the main - and mandatory - source of information for monitoring pregnancies, births and neonatal health in Italy. The BAC used in the province of Trento acquires the results of a vast range of infections in pregnancy. The data collected from the BAC were integrated with those provided by the Hospital Information System (SIO). The occurrence of neonatal GBS infection was investigated on 2019 birth cohort, using the hospital discharge archive as an ancillary information source. Between 2015-2019, 20,905 pregnant women received care at maternity units of the province of Trento, Italy, of whom 25.5% were foreigners. The average coverage of GBS testing in pregnancy was 91.8% (95% CI 91.25-92.35) without significant variations from one year to the next. Test coverage varies in relation to maternity units and some socio-demographic characteristics of mothers. The average proportion of GBS positive cases over the study period was 21.0% (95% CI 20.7-21.3), a value that does not show statistically significant changes from one year to the next. The proportion of positive cases appears uneven among the subgroups of pregnant women considered, even if the differences are not statistically significant. In the 2019 birth cohort, newborns to GBS-positive mothers had an excess of stillbirths, of those born with Apgar at 5 minutes <7 and hospitalized at birth. However, these excesses were not statistically significant. Intravenous Antibiotic Prophylaxis (IAP) was performed in 86.8% of births from GBS positive mothers who had an indication for IAP. IAP was inadequate in 7.4% of the GBS positive mothers. Postnatal evaluation of 783 live births to GBS positive mothers identified 3 cases of early neonatal GBS infection. The incidence of neonatal GBS infection over the whole series of live births is 0.71/1,000 (95% CI 0.56-0.86), 0.68/1000 (CI 95% 0.55-0.79) in Italians and 1.07/1000 (95% CI 0.45-1.65) in foreigners. Data collection on infections in pregnancy through BAC allows area-based assessment. The quality of the data recorded in the BAC can be considered satisfactory but it was necessary to access to other information sources. The local availability of various information sources should allow periodic audits and closer monitoring of neonatal GBS infection.

这项研究分析了意大利特伦托省妊娠期乙型链球菌(GBS)感染的趋势,该省开展妊娠期GBS感染普查已有一段时间。2015-2019年间在当地妇产医院分娩的孕妇数据来自出生证明(BAC),这是意大利监测妊娠、分娩和新生儿健康的主要和强制性信息来源。特伦托省使用的 BAC 获取了大量孕期感染的结果。从 BAC 收集到的数据与医院信息系统(SIO)提供的数据进行了整合。利用医院出院档案作为辅助信息来源,调查了 2019 年出生队列中新生儿 GBS 感染的发生情况。2015-2019年间,20905名孕妇在意大利特伦托省的产科医院接受了治疗,其中25.5%为外国人。妊娠期 GBS 检测的平均覆盖率为 91.8%(95% CI 91.25-92.35),每年之间无明显差异。检测覆盖率因产科医院和母亲的一些社会人口特征而异。在研究期间,GBS 阳性病例的平均比例为 21.0%(95% CI 20.7-21.3),这一数值在不同年份之间没有明显的统计学变化。在所考虑的孕妇亚群中,阳性病例的比例似乎并不均衡,尽管差异在统计学上并不显著。在 2019 年的出生组群中,GBS 阳性母亲所生的新生儿中死胎过多,阿普加评分为 5 分的新生儿中死胎过多,阿普加评分为 5 分的新生儿中死胎过多。
{"title":"Screening of group B Streptococcus infection in pregnancy and neonatal outcomes in the province of Trento, Italy.","authors":"Silvano Piffer, Roberto Rizzello, Mariangela Pedron, Laura Dellanna, Anna Lina Lauriola","doi":"10.53854/liim-3002-11","DOIUrl":"10.53854/liim-3002-11","url":null,"abstract":"<p><p>The study analyzes the trend of group B streptococcal (GBS) infection in pregnancy in the province of Trento, Italy, where a universal screening of GBS infection in pregnancy has been active for some time. Data from pregnant women who gave birth at local maternity units between 2015-2019 were obtained from birth attendance certificates (BAC), the main - and mandatory - source of information for monitoring pregnancies, births and neonatal health in Italy. The BAC used in the province of Trento acquires the results of a vast range of infections in pregnancy. The data collected from the BAC were integrated with those provided by the Hospital Information System (SIO). The occurrence of neonatal GBS infection was investigated on 2019 birth cohort, using the hospital discharge archive as an ancillary information source. Between 2015-2019, 20,905 pregnant women received care at maternity units of the province of Trento, Italy, of whom 25.5% were foreigners. The average coverage of GBS testing in pregnancy was 91.8% (95% CI 91.25-92.35) without significant variations from one year to the next. Test coverage varies in relation to maternity units and some socio-demographic characteristics of mothers. The average proportion of GBS positive cases over the study period was 21.0% (95% CI 20.7-21.3), a value that does not show statistically significant changes from one year to the next. The proportion of positive cases appears uneven among the subgroups of pregnant women considered, even if the differences are not statistically significant. In the 2019 birth cohort, newborns to GBS-positive mothers had an excess of stillbirths, of those born with Apgar at 5 minutes <7 and hospitalized at birth. However, these excesses were not statistically significant. Intravenous Antibiotic Prophylaxis (IAP) was performed in 86.8% of births from GBS positive mothers who had an indication for IAP. IAP was inadequate in 7.4% of the GBS positive mothers. Postnatal evaluation of 783 live births to GBS positive mothers identified 3 cases of early neonatal GBS infection. The incidence of neonatal GBS infection over the whole series of live births is 0.71/1,000 (95% CI 0.56-0.86), 0.68/1000 (CI 95% 0.55-0.79) in Italians and 1.07/1000 (95% CI 0.45-1.65) in foreigners. Data collection on infections in pregnancy through BAC allows area-based assessment. The quality of the data recorded in the BAC can be considered satisfactory but it was necessary to access to other information sources. The local availability of various information sources should allow periodic audits and closer monitoring of neonatal GBS infection.</p>","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88425630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of gonococcal and non-gonococcal infections in women referred to obstetrics and gynecology clinics. 妇女的淋球菌和非淋球菌感染的流行率转介到妇产科诊所。
H. Kazemian, Morteza Karami Zarandi, Zeinab Zargoush, S. Ghafourian, N. Sadeghifard, A. Jalilian, M. Shafieian, I. Pakzad
Bacterial vaginosis is a condition caused by changes in the vaginal microbial ecosystem and increases the risk of preterm delivery, premature rupture of membranes, endometritis, and weight loss of the baby. This study aimed to evaluate the frequency of gonococcal and non-gonococcal genital infections in women referred to clinics in Ilam, Iran. Two swab samples were taken from each patient using a sterile swab, one swab was placed in a THB medium for the culture of Streptococcus agalactiae and the other in PBS buffer for PCR. PCR method was conducted for the identification of the other bacterial agents such as Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, and also S. agalactiae. Sampling was performed on 169 women with symptomatic vaginosis. The frequency of S. agalactiae by culture and PCR methods was 4.7% (8 samples) and 13.6% (23 samples) respectively. Also, 6.5% (11 samples), 3.5% (6 samples), 4.1% (7 samples), 1.2% (2 samples), and 0% of the samples were positive for N. gonorrhoeae, M. genitalium, M. hominis, U. urealyticum and C. trachomatis by PCR method. Except for a significant association between S. agalactiae colonization and abortion, there was no significant correlation between the prevalence of these bacteria and the patient's age, age of marriage, number of deliveries, and number of abortions. Overall, the prevalence of gonococcal and non-gonococcal infection in women referred to clinics in Ilam is similar to the other parts of Iran.
细菌性阴道病是一种由阴道微生物生态系统变化引起的疾病,会增加早产、胎膜早破、子宫内膜炎和婴儿体重减轻的风险。本研究旨在评估伊朗伊拉姆诊所妇女的淋球菌和非淋球菌生殖器感染的频率。使用无菌拭子从每位患者身上提取两个拭子样本,一个拭子置于THB培养基中培养无乳链球菌,另一个拭子置于PBS缓冲液中进行PCR。采用PCR法对淋病奈瑟菌、沙眼衣原体、生殖支原体、人支原体、解脲原体、无乳链球菌等细菌进行鉴定。对169例有症状性阴道病的妇女进行了抽样。培养法和PCR法检测无乳链球菌的频率分别为4.7%(8份)和13.6%(23份)。分别有6.5%(11份)、3.5%(6份)、4.1%(7份)、1.2%(2份)和0%的样本检测出淋病奈索菌、生殖支原体、人原体、解脲原体和沙眼原体。除了无乳链球菌定殖与流产之间存在显著相关性外,这些细菌的流行与患者的年龄、结婚年龄、分娩次数和流产次数之间没有显著相关性。总体而言,在伊拉姆的诊所就诊的妇女中,淋球菌和非淋球菌感染的患病率与伊朗其他地区相似。
{"title":"The prevalence of gonococcal and non-gonococcal infections in women referred to obstetrics and gynecology clinics.","authors":"H. Kazemian, Morteza Karami Zarandi, Zeinab Zargoush, S. Ghafourian, N. Sadeghifard, A. Jalilian, M. Shafieian, I. Pakzad","doi":"10.53854/liim-3002-10","DOIUrl":"https://doi.org/10.53854/liim-3002-10","url":null,"abstract":"Bacterial vaginosis is a condition caused by changes in the vaginal microbial ecosystem and increases the risk of preterm delivery, premature rupture of membranes, endometritis, and weight loss of the baby. This study aimed to evaluate the frequency of gonococcal and non-gonococcal genital infections in women referred to clinics in Ilam, Iran. Two swab samples were taken from each patient using a sterile swab, one swab was placed in a THB medium for the culture of Streptococcus agalactiae and the other in PBS buffer for PCR. PCR method was conducted for the identification of the other bacterial agents such as Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, and also S. agalactiae. Sampling was performed on 169 women with symptomatic vaginosis. The frequency of S. agalactiae by culture and PCR methods was 4.7% (8 samples) and 13.6% (23 samples) respectively. Also, 6.5% (11 samples), 3.5% (6 samples), 4.1% (7 samples), 1.2% (2 samples), and 0% of the samples were positive for N. gonorrhoeae, M. genitalium, M. hominis, U. urealyticum and C. trachomatis by PCR method. Except for a significant association between S. agalactiae colonization and abortion, there was no significant correlation between the prevalence of these bacteria and the patient's age, age of marriage, number of deliveries, and number of abortions. Overall, the prevalence of gonococcal and non-gonococcal infection in women referred to clinics in Ilam is similar to the other parts of Iran.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78234265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of lethality in severe leptospirosis in Transcarpathian region of Ukraine. 乌克兰外喀尔巴阡地区严重钩端螺旋体病致死率预测因素。
P. Petakh, A. Nykyforuk
Leptospirosis is one of the most widespread zoonoses in the Transcarpathian region, with an average lethality of 12.5%. To determine the predictors of lethality, a retrospective study of 97 medical records of patients with leptospirosis in the period from 2009 to 2018 was conducted. Quantitative variables in the presence of normal distribution were compared using a paired Student's t-test, and in the case of an abnormal distribution, the Mann-Whitney U test was used. The criterion χ2 was used for qualitative variables. Multivariate analysis was used for the calculation of the Odds ratio. The following factors that are associated with death from leptospirosis have been identified: total bilirubin greater than 300 mcmol/L (OR, 4.25; 95% confidence interval [CI], 1.57-11.53), platelets less than 50 × (109/L) (OR, 3.95; 95% confidence interval [CI], 1.45-10.73), creatinine above 200 mcmol/L (OR, 1.95; 95% confidence interval [CI], 1.47-2.60) and jaundice (OR, 1.39; 95% confidence interval [CI], 1.21-1.60). Detection of these predictors will help to quickly identify a patient at risk of severe course of the disease and death, which will allow deciding on the use of early intensive care.
钩端螺旋体病是外喀尔巴阡地区最普遍的人畜共患病之一,平均致死率为12.5%。为了确定致死率的预测因素,对2009 - 2018年97例钩端螺旋体病患者的病历进行了回顾性研究。对于正态分布的定量变量,采用配对Student's t检验进行比较,对于异常分布的定量变量,采用Mann-Whitney U检验。定性变量采用χ2判别标准。采用多变量分析计算优势比。已确定与钩端螺旋体病死亡相关的下列因素:总胆红素大于300 mcmol/L (OR, 4.25;95%可信区间[CI], 1.57-11.53),血小板小于50 × (109/L) (OR, 3.95;95%可信区间[CI], 1.45-10.73),肌酐高于200 mcmol/L (OR, 1.95;95%可信区间[CI], 1.47-2.60)和黄疸(OR, 1.39;95%可信区间[CI], 1.21-1.60)。发现这些预测因素将有助于迅速确定有严重病程和死亡风险的患者,从而决定是否使用早期重症监护。
{"title":"Predictors of lethality in severe leptospirosis in Transcarpathian region of Ukraine.","authors":"P. Petakh, A. Nykyforuk","doi":"10.53854/liim-3002-13","DOIUrl":"https://doi.org/10.53854/liim-3002-13","url":null,"abstract":"Leptospirosis is one of the most widespread zoonoses in the Transcarpathian region, with an average lethality of 12.5%. To determine the predictors of lethality, a retrospective study of 97 medical records of patients with leptospirosis in the period from 2009 to 2018 was conducted. Quantitative variables in the presence of normal distribution were compared using a paired Student's t-test, and in the case of an abnormal distribution, the Mann-Whitney U test was used. The criterion χ2 was used for qualitative variables. Multivariate analysis was used for the calculation of the Odds ratio. The following factors that are associated with death from leptospirosis have been identified: total bilirubin greater than 300 mcmol/L (OR, 4.25; 95% confidence interval [CI], 1.57-11.53), platelets less than 50 × (109/L) (OR, 3.95; 95% confidence interval [CI], 1.45-10.73), creatinine above 200 mcmol/L (OR, 1.95; 95% confidence interval [CI], 1.47-2.60) and jaundice (OR, 1.39; 95% confidence interval [CI], 1.21-1.60). Detection of these predictors will help to quickly identify a patient at risk of severe course of the disease and death, which will allow deciding on the use of early intensive care.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90376718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors. 两个转诊中心卡介苗膀胱内给药后的BCGitis:临床特征和危险因素
I. De Benedetto, A. Barco, M. Rossi, G. Lapadula, T. Lupia, P. Bonfanti, S. Bonora, G. di Perri, A. Calcagno
Bacillus Calmette-Guerin (BCG) is commonly and safely used as intravesical instillation to treat bladder cancer. Adverse effects are widely described in case report and series with a broad range of clinical presentations known as "BCGitis". Moreover, microbiological identification is often inconclusive leading to diagnostic uncertainty and no standardisation of definitions is available. We retrospectively collected all cases of BCGitis (n=19) after BCG intravesical administration occurred in 2 major Italian hospitals in the last 10 years. Median age was 71.8 years and among comorbidities hypertension affected 60% of patients. The delay in the onset of symptoms was < one week and an inverse correlation was observed between the number of instillations and the time to the onset of symptoms. Moreover, a febrile presentation was the commonest clinical symptom (85%) and an interstitial or micronodular pattern at chest X-ray or CT scan was found positive in about 70% and 90% of cases, respectively. Larger cohorts are needed in order to inform clinically relevant algorythms for this uncommon disease.
卡介苗(Bacillus calmetet - guerin, BCG)是膀胱内注射治疗膀胱癌常用且安全的方法。不良反应在病例报告和系列中被广泛描述,具有广泛的临床表现,称为“BCGitis”。此外,微生物鉴定往往是不确定的,导致诊断的不确定性,没有标准化的定义。我们回顾性收集了意大利2家主要医院近10年来膀胱内注射卡介苗后发生的所有BCGitis病例(n=19)。中位年龄为71.8岁,在合并症中,高血压影响了60%的患者。症状出现的延迟时间<一周,注射次数与症状出现时间呈负相关。此外,发热是最常见的临床症状(85%),在胸部x线或CT扫描中分别有70%和90%的病例呈间质性或小结节型。需要更大的队列,以便为这种罕见疾病的临床相关算法提供信息。
{"title":"BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors.","authors":"I. De Benedetto, A. Barco, M. Rossi, G. Lapadula, T. Lupia, P. Bonfanti, S. Bonora, G. di Perri, A. Calcagno","doi":"10.53854/liim-3002-9","DOIUrl":"https://doi.org/10.53854/liim-3002-9","url":null,"abstract":"Bacillus Calmette-Guerin (BCG) is commonly and safely used as intravesical instillation to treat bladder cancer. Adverse effects are widely described in case report and series with a broad range of clinical presentations known as \"BCGitis\". Moreover, microbiological identification is often inconclusive leading to diagnostic uncertainty and no standardisation of definitions is available. We retrospectively collected all cases of BCGitis (n=19) after BCG intravesical administration occurred in 2 major Italian hospitals in the last 10 years. Median age was 71.8 years and among comorbidities hypertension affected 60% of patients. The delay in the onset of symptoms was < one week and an inverse correlation was observed between the number of instillations and the time to the onset of symptoms. Moreover, a febrile presentation was the commonest clinical symptom (85%) and an interstitial or micronodular pattern at chest X-ray or CT scan was found positive in about 70% and 90% of cases, respectively. Larger cohorts are needed in order to inform clinically relevant algorythms for this uncommon disease.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87063409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recrudescence of Plasmodium falciparum malaria 5 years after treatment in an HIV migrant: a case report with a peculiar presentation. 一名HIV移民治疗5年后恶性疟原虫疟疾复发:一例特殊表现的病例报告。
Arianna Forniti, N. Riccardi, Pietro Sponga, C. Buono, R. Iapoce, L. R. Suardi, G. Tiseo, M. Falcone, F. Menichetti
In the last two decades, several cases of delayed-onset malaria in migrants from endemic areas were reported. The decrease of acquired immunity over time, often enhanced by immune suppression, represents a possible underlying mechanism for recrudescence. Here we describe a case of Plasmodium falciparum malaria occurring five years after exposure in a patient infected with human immunodeficiency virus, originating from Ivory Coast. Peculiarly, bilateral subsegmental pulmonary embolism in the absence of deep venous thrombosis was also detected, requiring anticoagulant therapy. Treatment with dihydroartemisinin/piperaquine was followed by clearance of trophozoites and the patient was discharged home.
在过去二十年中,据报道,来自流行地区的移民中有几例延迟发病的疟疾病例。随着时间的推移,获得性免疫力的下降,往往因免疫抑制而增强,这可能是复发的潜在机制。在这里,我们描述了恶性疟原虫疟疾的病例发生在接触五年后的病人感染人类免疫缺陷病毒,起源于象牙海岸。特别的是,在没有深静脉血栓形成的情况下,也可以检测到双侧亚节段性肺栓塞,需要抗凝治疗。双氢青蒿素/哌喹治疗后,滋养体清除,患者出院回家。
{"title":"Recrudescence of Plasmodium falciparum malaria 5 years after treatment in an HIV migrant: a case report with a peculiar presentation.","authors":"Arianna Forniti, N. Riccardi, Pietro Sponga, C. Buono, R. Iapoce, L. R. Suardi, G. Tiseo, M. Falcone, F. Menichetti","doi":"10.53854/liim-3002-18","DOIUrl":"https://doi.org/10.53854/liim-3002-18","url":null,"abstract":"In the last two decades, several cases of delayed-onset malaria in migrants from endemic areas were reported. The decrease of acquired immunity over time, often enhanced by immune suppression, represents a possible underlying mechanism for recrudescence. Here we describe a case of Plasmodium falciparum malaria occurring five years after exposure in a patient infected with human immunodeficiency virus, originating from Ivory Coast. Peculiarly, bilateral subsegmental pulmonary embolism in the absence of deep venous thrombosis was also detected, requiring anticoagulant therapy. Treatment with dihydroartemisinin/piperaquine was followed by clearance of trophozoites and the patient was discharged home.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90357069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recent breakthroughs in the treatment of chronic hepatitis Delta. 慢性丁型肝炎治疗的最新突破。
G. Brancaccio, L. Gaeta, A. Vitale, G. Gaeta
Hepatitis Delta virus (HDV) is responsible for the most aggressive form of chronic hepatitis, which may evolve towards cirrhosis, hepatocellular carcinoma and death within few years. During the last 30 years the only available therapy was interferon or peg-IFN, which was characterized by poor tolerability and modest results. The detailed knowledge of the HDV replication cycle and its interaction with HBV allowed the introduction of new drugs which are currently in phase II or III of experimentation. Basically, bulevirtide, to date the only one approved by EMA, inhibits the entry of the virus into the hepatocytes and hence its intrahepatic spread; lonafarnib inhibits the pharnesylation process of the L-HDAg, which is critical for the assembly of the HDV virion; the nucleic acid polymers (NAPs) mainly block the production/release of HBsAg. The available clinical trials with these compounds showed an excellent anti-viral activity against HDV.
丁型肝炎病毒(HDV)是最具侵袭性的慢性肝炎,可在几年内演变为肝硬化、肝细胞癌和死亡。在过去的30年里,唯一可用的治疗方法是干扰素或peg-IFN,其特点是耐受性差,效果一般。对HDV复制周期及其与HBV相互作用的详细了解使目前处于第二或第三阶段实验的新药得以引入。基本上,迄今为止唯一获得EMA批准的布来韦肽可以抑制病毒进入肝细胞,从而抑制其肝内扩散;lonafarnib抑制L-HDAg的pharnesylation过程,该过程对HDV病毒粒子的组装至关重要;核酸聚合物(nap)主要阻断HBsAg的产生/释放。现有的临床试验表明,这些化合物对HDV具有良好的抗病毒活性。
{"title":"Recent breakthroughs in the treatment of chronic hepatitis Delta.","authors":"G. Brancaccio, L. Gaeta, A. Vitale, G. Gaeta","doi":"10.53854/liim-3002-5","DOIUrl":"https://doi.org/10.53854/liim-3002-5","url":null,"abstract":"Hepatitis Delta virus (HDV) is responsible for the most aggressive form of chronic hepatitis, which may evolve towards cirrhosis, hepatocellular carcinoma and death within few years. During the last 30 years the only available therapy was interferon or peg-IFN, which was characterized by poor tolerability and modest results. The detailed knowledge of the HDV replication cycle and its interaction with HBV allowed the introduction of new drugs which are currently in phase II or III of experimentation. Basically, bulevirtide, to date the only one approved by EMA, inhibits the entry of the virus into the hepatocytes and hence its intrahepatic spread; lonafarnib inhibits the pharnesylation process of the L-HDAg, which is critical for the assembly of the HDV virion; the nucleic acid polymers (NAPs) mainly block the production/release of HBsAg. The available clinical trials with these compounds showed an excellent anti-viral activity against HDV.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90196341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Rhino-orbito-cerebral mucormycosis in an acute lymphoblastic leukemia pediatric patient. Case report and review of literature. 急性淋巴细胞白血病患儿鼻-眶-脑毛霉菌病。病例报告及文献复习。
Cindy Carolina Abril Rincón, Carlos Ramiro Silva-Ramos, Joel Amuruz Arancibia, Ma Camila Prada-Avella, A. Suárez
Mucormycosis is a disease caused by opportunistic fungi of the order Mucorales that generally affects immunocompromised patients or those with underlying disease. It has a high mortality rate and is the third most common invasive fungal infection. The following is a case report of a 12-year-old pediatric patient diagnosed with B-cell acute lymphoblastic leukemia, who presented an aggressive infectious disease two months after beginning chemotherapy, which began in the right frontal and maxillary sinuses, with subsequent progression and extension, progressively deteriorating the patient's clinical status. Culture and biopsy of the affected areas were performed, confirming by histopathology and isolation a rhino-orbito-cerebral mucormycosis due to Actinomucor elegans. The patient was treated with specific antifungal therapy as an inpatient and left the service after obtaining negative cultures, continuing with outpatient antifungal treatment.
毛霉菌病是一种由毛霉菌目的机会性真菌引起的疾病,通常影响免疫功能低下的患者或有基础疾病的患者。它的死亡率很高,是第三大最常见的侵袭性真菌感染。以下是一个12岁的儿童b细胞急性淋巴细胞白血病患者的病例报告,他开始化疗两个月后出现侵袭性感染性疾病,始于右侧额窦和上颌窦,随后进展和扩展,患者的临床状况逐渐恶化。对感染区域进行培养和活检,通过组织病理学和分离证实了由秀丽放线菌引起的鼻-眶-脑毛霉病。患者作为住院患者接受特异性抗真菌治疗,在获得阴性培养后出院,继续门诊抗真菌治疗。
{"title":"Rhino-orbito-cerebral mucormycosis in an acute lymphoblastic leukemia pediatric patient. Case report and review of literature.","authors":"Cindy Carolina Abril Rincón, Carlos Ramiro Silva-Ramos, Joel Amuruz Arancibia, Ma Camila Prada-Avella, A. Suárez","doi":"10.53854/liim-3002-17","DOIUrl":"https://doi.org/10.53854/liim-3002-17","url":null,"abstract":"Mucormycosis is a disease caused by opportunistic fungi of the order Mucorales that generally affects immunocompromised patients or those with underlying disease. It has a high mortality rate and is the third most common invasive fungal infection. The following is a case report of a 12-year-old pediatric patient diagnosed with B-cell acute lymphoblastic leukemia, who presented an aggressive infectious disease two months after beginning chemotherapy, which began in the right frontal and maxillary sinuses, with subsequent progression and extension, progressively deteriorating the patient's clinical status. Culture and biopsy of the affected areas were performed, confirming by histopathology and isolation a rhino-orbito-cerebral mucormycosis due to Actinomucor elegans. The patient was treated with specific antifungal therapy as an inpatient and left the service after obtaining negative cultures, continuing with outpatient antifungal treatment.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81345832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Uncommon lymphocutaneous cellulitis after insect bite: a case report of primary cutaneous nocardiosis and literature review. 昆虫叮咬后罕见淋巴皮肤蜂窝织炎:原发性皮肤诺卡菌病1例并文献复习。
Antonio Lovecchio, Giulia Bazzacco, S. di Bella, N. di Meo, R. Luzzati
Nocardia is a genus of aerobic actinomycetes that are usually responsible for opportunistic infection in immunocompromised patients. Less frequently nocardiosis can interest immunocompetent population, causing especially primary cutaneous infections. Cutaneous involvement by Nocardia spp. may occur mostly as one of four clinical manifestations: superficial cellulitis or abscess, mycetoma, lymphocutaneous (also defined "sporotrichoid") infection and secondary cutaneous involvement from systemic disease. Infections usually present after minor local injury, especially in traumatic outdoor activities (e.g. gardeners, farmers, road accidents), with subsequent environmental contamination of the wound. In sporadic cases cutaneous infection follows an insect bite. Microbiological diagnosis is often difficult to obtain and N. brasiliensis is the species isolated in most cases (80%). We present the case of a 45-year-old female with fever and a painful and necrotizing lesion on her right leg with secondary ascending lesions occurred on the homolateral knee and consensual groin lymphadenopathy after insect sting (maybe a spider bite). Cultures on skin biopsy identified Nocardia brasiliensis. Infection was completely healed after 5 months of targeted antibiotic therapy. In addition, we performed a literature review of all cutaneous nocardiosis cases in immunocompetent individuals, finding that only in 22 cases the infection presented after insect bite; in most of these cases lymphocutaneous manifestation was seen and N. brasiliensis was the Nocardia species isolated. Our case, along with others in literature, reveals that the real burden of soft-tissues nocardiosis seems low but probably many cases might go undiagnosed because of difficulties in microbiology diagnosis. Primary cutaneous nocardiosis should be included in the diagnostic pathway in cases of cellulitis following insect bite or sting, especially when localized to extremities.
诺卡菌是一种需氧放线菌属,通常导致免疫功能低下患者的机会性感染。诺卡菌病很少引起免疫正常人群的兴趣,尤其引起原发性皮肤感染。诺卡菌感染皮肤主要表现为以下四种临床表现之一:浅表蜂窝织炎或脓肿、足菌肿、淋巴皮肤(也定义为“孢子毛状体”)感染和全身性疾病继发皮肤受累。感染通常在局部轻微损伤后出现,特别是在创伤性户外活动中(如园丁、农民、道路事故),随后伤口受到环境污染。在散发病例中,昆虫叮咬后皮肤感染。微生物学诊断通常难以获得,在大多数情况下(80%),巴西乳杆菌是分离的物种。我们报告一例45岁女性患者,在昆虫蜇伤(可能是蜘蛛咬伤)后,右腿出现发热、疼痛和坏死性病变,并在同侧膝盖发生继发上升病变和双方同意的腹股沟淋巴结病。皮肤活检培养鉴定为巴西诺卡菌。经过5个月的靶向抗生素治疗,感染完全愈合。此外,我们对所有免疫正常个体的皮肤诺卡菌病病例进行了文献回顾,发现只有22例感染是在昆虫叮咬后出现的;这些病例大多有淋巴皮肤表现,巴西奈瑟菌为分离的诺卡菌种。我们的病例以及文献中的其他病例表明,软组织诺卡菌病的真正负担似乎很低,但可能由于微生物学诊断的困难,许多病例可能未被诊断。在昆虫叮咬或蜇伤后蜂窝织炎的病例中,特别是当局限于四肢时,原发性皮肤诺卡菌病应包括在诊断途径中。
{"title":"Uncommon lymphocutaneous cellulitis after insect bite: a case report of primary cutaneous nocardiosis and literature review.","authors":"Antonio Lovecchio, Giulia Bazzacco, S. di Bella, N. di Meo, R. Luzzati","doi":"10.53854/liim-3002-15","DOIUrl":"https://doi.org/10.53854/liim-3002-15","url":null,"abstract":"Nocardia is a genus of aerobic actinomycetes that are usually responsible for opportunistic infection in immunocompromised patients. Less frequently nocardiosis can interest immunocompetent population, causing especially primary cutaneous infections. Cutaneous involvement by Nocardia spp. may occur mostly as one of four clinical manifestations: superficial cellulitis or abscess, mycetoma, lymphocutaneous (also defined \"sporotrichoid\") infection and secondary cutaneous involvement from systemic disease. Infections usually present after minor local injury, especially in traumatic outdoor activities (e.g. gardeners, farmers, road accidents), with subsequent environmental contamination of the wound. In sporadic cases cutaneous infection follows an insect bite. Microbiological diagnosis is often difficult to obtain and N. brasiliensis is the species isolated in most cases (80%). We present the case of a 45-year-old female with fever and a painful and necrotizing lesion on her right leg with secondary ascending lesions occurred on the homolateral knee and consensual groin lymphadenopathy after insect sting (maybe a spider bite). Cultures on skin biopsy identified Nocardia brasiliensis. Infection was completely healed after 5 months of targeted antibiotic therapy. In addition, we performed a literature review of all cutaneous nocardiosis cases in immunocompetent individuals, finding that only in 22 cases the infection presented after insect bite; in most of these cases lymphocutaneous manifestation was seen and N. brasiliensis was the Nocardia species isolated. Our case, along with others in literature, reveals that the real burden of soft-tissues nocardiosis seems low but probably many cases might go undiagnosed because of difficulties in microbiology diagnosis. Primary cutaneous nocardiosis should be included in the diagnostic pathway in cases of cellulitis following insect bite or sting, especially when localized to extremities.","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90587998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Impact of COVID-19 severity on health-related quality of life among Saudi adult patients. COVID-19 严重程度对沙特成年患者健康相关生活质量的影响。
Ali Hassan A Alnasser, Jaffar A Al-Tawfiq, Mohammed Sheker H Al Kalif, Jasem Ahmad H Alburaih, Lubna Abdulaziz A AlHamad, Akilah Abdulkarim A Abadi, Dhia Abdulwahid A Alghanim, Alhassan Ahmed S Hamzi, Duaa Hussain M Al-Huraiz, Bian Abdo Mohammed Al-Haguri, Ebtihal Ali A Alawami, Hawra Abdulwahed I Khlitit, Sukainah Yousif I Almutawah, Ibtihal Faisal S AlEid, Zahra Shaker H Al-Kalaif

COVID-19 patients may experience varying degrees of symptom severity, significantly impacting the health-related quality of life. As a result, the current study examines the impact of symptom severity on health-related quality of life among Saudi adult COVID- 19 patients. In this cross-sectional study 310 adult COVID-19 patients were recruited through a snowball technique in Saudi Arabia. We used a questionnaire (SF-12 RAND tool questionnaire) that included three parts: sociodemographic factors, perception of degree severity of COVID-19 symptoms, and health-related quality of life (HRQoL). Out of 310 COVID-19 adult patients, 200 (64.5%) were female, 110 (35.5%) were between 30-49 years old. The mean scores of the HRQoL, physical components summary (PCS), and mental components summary (MCS) were 58.11±17.02, 71.32±23.72, and 44.91±17.94, respectively. Patients with very severe symptoms had the lowest HRQoL mean rank (120.39, P=0.023). There was a strong positive correlation between HRQoL and PCS (0.852) and HRQoL and MCS (0.730). However, PCS and MCS had a weak positive correlation (0.292). The severity of COVID-19 symptoms had a significant impact on HRQoL. Thus, it is essential to enhance the uptake of vaccines to decrease the risk of infections and avoid impact on quality of life.

COVID-19 患者可能会出现不同程度的症状严重性,严重影响与健康相关的生活质量。因此,本研究探讨了症状严重程度对沙特 COVID-19 成年患者健康相关生活质量的影响。在这项横断面研究中,我们通过滚雪球技术在沙特阿拉伯招募了 310 名 COVID-19 成年患者。我们使用的问卷(SF-12 RAND 工具问卷)包括三个部分:社会人口因素、COVID-19 症状严重程度感知和健康相关生活质量(HRQoL)。在 310 名 COVID-19 成年患者中,200 人(64.5%)为女性,110 人(35.5%)年龄在 30-49 岁之间。患者的 HRQoL、身体成分总结(PCS)和精神成分总结(MCS)的平均得分分别为(58.11±17.02)分、(71.32±23.72)分和(44.91±17.94)分。症状非常严重的患者的 HRQoL 平均值最低(120.39,P=0.023)。HRQoL 与 PCS(0.852)和 HRQoL 与 MCS(0.730)之间存在很强的正相关性。然而,PCS 和 MCS 的正相关性较弱(0.292)。COVID-19 症状的严重程度对 HRQoL 有显著影响。因此,必须提高疫苗接种率,以降低感染风险,避免影响生活质量。
{"title":"Impact of COVID-19 severity on health-related quality of life among Saudi adult patients.","authors":"Ali Hassan A Alnasser, Jaffar A Al-Tawfiq, Mohammed Sheker H Al Kalif, Jasem Ahmad H Alburaih, Lubna Abdulaziz A AlHamad, Akilah Abdulkarim A Abadi, Dhia Abdulwahid A Alghanim, Alhassan Ahmed S Hamzi, Duaa Hussain M Al-Huraiz, Bian Abdo Mohammed Al-Haguri, Ebtihal Ali A Alawami, Hawra Abdulwahed I Khlitit, Sukainah Yousif I Almutawah, Ibtihal Faisal S AlEid, Zahra Shaker H Al-Kalaif","doi":"10.53854/liim-3002-7","DOIUrl":"10.53854/liim-3002-7","url":null,"abstract":"<p><p>COVID-19 patients may experience varying degrees of symptom severity, significantly impacting the health-related quality of life. As a result, the current study examines the impact of symptom severity on health-related quality of life among Saudi adult COVID- 19 patients. In this cross-sectional study 310 adult COVID-19 patients were recruited through a snowball technique in Saudi Arabia. We used a questionnaire (SF-12 RAND tool questionnaire) that included three parts: sociodemographic factors, perception of degree severity of COVID-19 symptoms, and health-related quality of life (HRQoL). Out of 310 COVID-19 adult patients, 200 (64.5%) were female, 110 (35.5%) were between 30-49 years old. The mean scores of the HRQoL, physical components summary (PCS), and mental components summary (MCS) were 58.11±17.02, 71.32±23.72, and 44.91±17.94, respectively. Patients with very severe symptoms had the lowest HRQoL mean rank (120.39, <i>P</i>=0.023). There was a strong positive correlation between HRQoL and PCS (0.852) and HRQoL and MCS (0.730). However, PCS and MCS had a weak positive correlation (0.292). The severity of COVID-19 symptoms had a significant impact on HRQoL. Thus, it is essential to enhance the uptake of vaccines to decrease the risk of infections and avoid impact on quality of life.</p>","PeriodicalId":17977,"journal":{"name":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79020061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1